Your browser doesn't support javascript.
loading
Highly Thermotolerant SARS-CoV-2 Vaccine Elicits Neutralising Antibodies against Delta and Omicron in Mice.
Jansen van Vuren, Petrus; McAuley, Alexander J; Kuiper, Michael J; Singanallur, Nagendrakumar Balasubramanian; Bruce, Matthew P; Riddell, Shane; Goldie, Sarah; Mangalaganesh, Shruthi; Chahal, Simran; Drew, Trevor W; Blasdell, Kim R; Tachedjian, Mary; Caly, Leon; Druce, Julian D; Ahmed, Shahbaz; Khan, Mohammad Suhail; Malladi, Sameer Kumar; Singh, Randhir; Pandey, Suman; Varadarajan, Raghavan; Vasan, Seshadri S.
Afiliação
  • Jansen van Vuren P; Australian Centre for Disease Preparedness, Commonwealth Scientific and Industrial Research Organisation, Geelong, VIC 3220, Australia.
  • McAuley AJ; Australian Centre for Disease Preparedness, Commonwealth Scientific and Industrial Research Organisation, Geelong, VIC 3220, Australia.
  • Kuiper MJ; Data61, Commonwealth Scientific and Industrial Research Organisation, Docklands, VIC 3008, Australia.
  • Singanallur NB; Australian Centre for Disease Preparedness, Commonwealth Scientific and Industrial Research Organisation, Geelong, VIC 3220, Australia.
  • Bruce MP; Australian Centre for Disease Preparedness, Commonwealth Scientific and Industrial Research Organisation, Geelong, VIC 3220, Australia.
  • Riddell S; Australian Centre for Disease Preparedness, Commonwealth Scientific and Industrial Research Organisation, Geelong, VIC 3220, Australia.
  • Goldie S; Australian Centre for Disease Preparedness, Commonwealth Scientific and Industrial Research Organisation, Geelong, VIC 3220, Australia.
  • Mangalaganesh S; Australian Centre for Disease Preparedness, Commonwealth Scientific and Industrial Research Organisation, Geelong, VIC 3220, Australia.
  • Chahal S; Monash Biomedicine Discovery Institute, Monash University, Clayton, VIC 3800, Australia.
  • Drew TW; Australian Centre for Disease Preparedness, Commonwealth Scientific and Industrial Research Organisation, Geelong, VIC 3220, Australia.
  • Blasdell KR; Australian Centre for Disease Preparedness, Commonwealth Scientific and Industrial Research Organisation, Geelong, VIC 3220, Australia.
  • Tachedjian M; Australian Centre for Disease Preparedness, Commonwealth Scientific and Industrial Research Organisation, Geelong, VIC 3220, Australia.
  • Caly L; Australian Centre for Disease Preparedness, Commonwealth Scientific and Industrial Research Organisation, Geelong, VIC 3220, Australia.
  • Druce JD; Victorian Infectious Diseases Reference Laboratory, The Royal Melbourne Hospital and The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC 3000, Australia.
  • Ahmed S; Victorian Infectious Diseases Reference Laboratory, The Royal Melbourne Hospital and The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC 3000, Australia.
  • Khan MS; Molecular Biophysics Unit, Indian Institute of Science, Bengaluru 560012, India.
  • Malladi SK; Molecular Biophysics Unit, Indian Institute of Science, Bengaluru 560012, India.
  • Singh R; Molecular Biophysics Unit, Indian Institute of Science, Bengaluru 560012, India.
  • Pandey S; Mynvax Private Limited, ES-12, Incubation Centre, Society for Innovation and Development, Indian Institute of Science, Bengaluru 560012, India.
  • Varadarajan R; Mynvax Private Limited, ES-12, Incubation Centre, Society for Innovation and Development, Indian Institute of Science, Bengaluru 560012, India.
  • Vasan SS; Molecular Biophysics Unit, Indian Institute of Science, Bengaluru 560012, India.
Viruses ; 14(4)2022 04 13.
Article em En | MEDLINE | ID: mdl-35458530
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas contra COVID-19 / COVID-19 Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Viruses Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Austrália
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas contra COVID-19 / COVID-19 Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Viruses Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Austrália